Medical Supply Chain Workers Eligible For COVID-19 Vaccine on March 22nd

Menu

Special Impact Acquisition Company ("SPAC") Impact on MedTech

Special Impact Acquisition Company ("SPAC") Impact on MedTech

Monday, May 3, 2021 (8:00 AM - 9:30 AM) (EDT)

Description

This past year has been a boom for Special Purpose Acquisition Companies or "SPACs". Blank check companies have created a lot of exit opportunities for some investors in the industry. What does it mean for other investors, strategics, and emerging MedTech companies? Seth Damergy, Managing Director, Global Healthcare Group – Medical Devices and Technologies, UBS, will be the keynote speaker. He will be joined by John Delgado, Associate Director, Equity Capital Markets, UBS, and Michael Fantozzi Managing Member Mintz. They will discuss SPACs, what they are, who they benefit and key considerations when sponsoring or merging into. There will be a moderated Q&A period open to everyone. 

Register 

Event Contact
Brian Johnson
Monday, May 3, 2021 (8:00 AM - 9:30 AM) (EDT)
Powered By GrowthZone